TP53 and glioblastoma: Although these two types show no morphological differences, the genetic basis and the molecular pathways are different [6], with TP53 mutations occurring more commonly in secondary GBM and EGFR amplifications and PTEN mutations occurring more frequently in primary GBM [6, 9].